We are live on ! Find out more
AVNR

AVANIR PHARMACEUTICALS, INC CL A
AVNR

Delisted

AVNR was delisted on the 12th of January, 2015.

Back to rankings

0 hedge funds and large institutions have $0 invested in AVANIR PHARMACEUTICALS, INC CL A in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 163 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 166 → 0 (-166)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $2.74B → $0 (-$2.74B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 163

Holders
–
Holders Change
-166
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
163
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$653M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$398M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$152M
4
BFA
BlackRock Fund Advisors
California
-$146M
5
WIC
Water Island Capital
New York
-$89.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
– -$653M -38,513,713 Closed
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
– -$398M -23,465,722 Closed
Vanguard Group
3
Vanguard Group
Pennsylvania
– -$152M -8,989,968 Closed
BFA
4
BlackRock Fund Advisors
California
– -$146M -8,614,625 Closed
WIC
5
Water Island Capital
New York
– -$89.9M -5,306,423 Closed
BIT
6
BlackRock Institutional Trust
California
– -$84.2M -4,968,630 Closed
State Street
7
State Street
Massachusetts
– -$83.6M -4,931,809 Closed
Fidelity Investments
8
Fidelity Investments
Massachusetts
– -$79.1M -4,667,500 Closed
OAM
9
Oxford Asset Management
United Kingdom
– -$67.7M -4,008,100 Closed
AQR Capital Management
10
AQR Capital Management
Connecticut
– -$66.1M -3,898,656 Closed
AAM
11
Alpine Associates Management
Florida
– -$51.3M -3,027,177 Closed
MGM
12
Miura Global Management
New York
– -$46.7M -2,758,000 Closed
TCSAM
13
Tyrus Capital S.A.M.
Monaco
– -$38.9M -2,295,000 Closed
Barclays
14
Barclays
United Kingdom
– -$33.4M -2,085,179 Closed
Northern Trust
15
Northern Trust
Illinois
– -$34.4M -2,026,900 Closed
GF
16
Gabelli Funds
New York
– -$33.7M -1,986,189 Closed
JP Morgan Chase
17
JP Morgan Chase
New York
– -$28.7M -1,690,342 Closed
CS
18
Credit Suisse
Switzerland
– -$28M -1,651,002 Closed
JG
19
Jefferies Group
New York
– -$25.8M -1,521,986 Closed
OAC
20
OMERS Administration Corp
Ontario, Canada
– -$25.6M -1,510,600 Closed
UOC
21
UBS O'Connor
Illinois
– -$25.1M -1,481,900 Closed
Morgan Stanley
22
Morgan Stanley
New York
– -$23.6M -1,392,136 Closed
TCM
23
TimesSquare Capital Management
New York
– -$20.8M -1,227,503 Closed
Geode Capital Management
24
Geode Capital Management
Massachusetts
– -$18.9M -1,112,115 Closed
RSCM
25
Rock Springs Capital Management
Maryland
– -$18.6M -1,100,000 Closed
1
2 3 4 5

AVNR Hedge Fund Activity: Q1 2015 in Review

0 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in AVANIR PHARMACEUTICALS, INC CL A (AVNR) for Q1 2015, worth a combined $0 — down 100% from $2.74B a quarter earlier.

Sellers outnumbered buyers: 163 funds closed out of AVNR and 0 opened new positions — a net loss of 163 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $653M sold.

  • 0 institutional investors held AVANIR PHARMACEUTICALS, INC CL A (AVNR) as of Q1 2015, down from 166 in Q4 2014.
  • Funds reported $0 of AVANIR PHARMACEUTICALS, INC CL A stock for Q1 2015, down 100% quarter-over-quarter.
  • 0 funds opened new AVANIR PHARMACEUTICALS, INC CL A positions in Q1 2015 and 163 closed out, a net change of -163 holders.
  • The largest AVANIR PHARMACEUTICALS, INC CL A seller in Q1 2015 was Baker Bros. Advisors, an estimated $653M sold.

Based on aggregated 13F filings for Q1 2015.